Newsroom
Filters: Biosimilar medicines
x
2021x
“EU Industry Welcomes New Schengen Strategy’s Green Lanes” Read more
READ MORE“Too much at stake in the EU pharma strategy to […]
Read moreThe newly launched update of the industrial strategy aims to […]
Read moreChristoph Stoller will speak at 3A CONFERENCE – Availability, Accessibility, […]
Read moreFifteen years after the first global approval, biosimilar medicines systemically […]
Read moreBiosimilar medicines are increasingly relevant to public health as emphasised by the […]
Read moreIn response to the European Commission Trade Communication published on […]
Read more